Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Evaluation of the feasibility of intralymphatic injection of Diamyd®
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Neuroscience.
2019 (English)Independent thesis Advanced level (degree of Master (Two Years)), 20 credits / 30 HE creditsStudent thesis
Abstract [en]

Type 1 diabetes affects a person’s life on many levels in terms of quality of life, health, and socioeconomic costs both for the patients but also their families. As of now there is no therapy that targets the underlying mechanism of the disease. Intralymphatic administration of Diamyd® is being evaluated in a phase IIb clinical trial, DIAGNODE-2. The aim was to examine if the intralymphatic administration is feasible for both patients and medical professionals, and to identify any aspects of the procedure that can be improved. This feasibility study is based on interviews and answers received from questionnaires. The medical professionals that were selected were radiologists and study nurses that are involved in the DIAGNODE-2 trial. The radiologists were the prime focus and were thus interviewed through face-to-face/skype or phone and answered a questionnaire. Study nurses, having more contact with the patient, answered a survey in order to gain additional insights into the patient perspective.

 

The results show that the radiologists has a positive view towards the administration procedure, which was described as easy and safe. According to the study nurses the patients accept the procedure and they agreed that the patients understand the injection procedure once they received the information. In terms of the emotional state of the patients they were a bit nervous, but they became calmer after receiving the first injection. Based on the above-mentioned findings the intralymphatic injection procedure is described as feasible and has the potential to become a part of the standard clinical routine.

Place, publisher, year, edition, pages
2019. , p. 47
Keywords [en]
GABA, GAD. GAD65, intralymphatic injection, intralymphatic immunotherapy, type 1 diabetes, clinical trial, DIAGNODE-2, feasibility study, questionnaire, interview, radiologists, study nurses, injection procedure
National Category
Clinical Medicine Endocrinology and Diabetes
Identifiers
URN: urn:nbn:se:uu:diva-389630OAI: oai:DiVA.org:uu-389630DiVA, id: diva2:1338005
Educational program
Master Programme in Biomedicine
Supervisors
Examiners
Available from: 2019-09-09 Created: 2019-07-18 Last updated: 2019-09-09Bibliographically approved

Open Access in DiVA

fulltext(947 kB)23 downloads
File information
File name FULLTEXT01.pdfFile size 947 kBChecksum SHA-512
8648518273b51c7e511184f5fa4b8bc4add8019b58b439df74d6f1dadf8018adf0c9028fdc9964b123e539006d60a055eb848f61b00cdaf3bc578ff6eed9318e
Type fulltextMimetype application/pdf

By organisation
Department of Neuroscience
Clinical MedicineEndocrinology and Diabetes

Search outside of DiVA

GoogleGoogle Scholar
Total: 23 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

urn-nbn

Altmetric score

urn-nbn
Total: 272 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf